- Home
- CFFI vs TSHA Comparison
CFFI vs TSHA Comparison
Compare CFFI & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFFI
- TSHA
- Stock Information
- Founded
- CFFI 1927
- TSHA 2019
- Country
- CFFI United States
- TSHA United States
- Employees
- CFFI N/A
- TSHA N/A
- Industry
- CFFI Major Banks
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- CFFI Finance
- TSHA Health Care
- Exchange
- CFFI Nasdaq
- TSHA Nasdaq
- Market Cap
- CFFI 245.8M
- TSHA 397.8M
- IPO Year
- CFFI 1998
- TSHA 2020
- Fundamental
- Price
- CFFI $67.43
- TSHA $2.14
- Analyst Decision
- CFFI
- TSHA Strong Buy
- Analyst Count
- CFFI 0
- TSHA 8
- Target Price
- CFFI N/A
- TSHA $6.63
- AVG Volume (30 Days)
- CFFI 8.5K
- TSHA 2.9M
- Earning Date
- CFFI 04-24-2025
- TSHA 05-16-2025
- Dividend Yield
- CFFI 2.88%
- TSHA N/A
- EPS Growth
- CFFI 9.97
- TSHA N/A
- EPS
- CFFI 6.67
- TSHA N/A
- Revenue
- CFFI $116,421,000.00
- TSHA $8,333,000.00
- Revenue This Year
- CFFI N/A
- TSHA N/A
- Revenue Next Year
- CFFI N/A
- TSHA N/A
- P/E Ratio
- CFFI $9.56
- TSHA N/A
- Revenue Growth
- CFFI 0.67
- TSHA N/A
- 52 Week Low
- CFFI $40.99
- TSHA $1.05
- 52 Week High
- CFFI $89.90
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- CFFI 54.54
- TSHA 59.68
- Support Level
- CFFI $63.81
- TSHA $1.85
- Resistance Level
- CFFI $68.16
- TSHA $2.28
- Average True Range (ATR)
- CFFI 1.58
- TSHA 0.26
- MACD
- CFFI 0.60
- TSHA 0.03
- Stochastic Oscillator
- CFFI 92.15
- TSHA 56.52
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum revenue from the Community Banking segment.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.